BMO Capital Markets’s $170 target on MRK

MRK Merck & Co.

$149 → $170 (+14%) by Aug 2027

Outperform · raises · said Aug 20, 2026 · 12-month default horizon

Open: judged on the close on Aug 20, 2027

The article this target came from

MRK Maintains by BMO Capital -- Price Target Raised to $170.00

GuruFocus · Aug 20, 2026

BMO Capital Markets raised its price target to $170 from $142, maintaining an "outperform" rating, in a report released Thursday, August 20, 2026.

BMO Capital Markets’s track record → Merck & Co. →

A fact about what BMO Capital Markets published, as reported by GuruFocus, not a recommendation from Dalsna Finance; BMO Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.